Loading...

Gerald L Denardo

Title(s)Professor Emeritus, INTERNAL MEDICINE
SchoolUniversity of California, Davis
Phone916-734-3787
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Klein M, Lotem M, Peretz T, Zwas ST, Mizrachi S, Liberman Y, Chisin R, Schachter J, Ron IG, Iosilevsky G, Kennedy JA, Revskaya E, de Kater AW, Banaga E, Klutzaritz V, Friedmann N, Galun E, Denardo GL, Denardo SJ, Casadevall A, Dadachova E, Thornton GB. Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma. J Skin Cancer. 2013; 2013:828329. PMID: 23365757.
      View in: PubMed
    2. DeNardo GL, DeNardo SJ. Concepts, consequences, and implications of theranosis. Semin Nucl Med. 2012 May; 42(3):147-50. PMID: 22475423.
      View in: PubMed
    3. Denardo GL, Macey DJ. Pretherapy prediction of nephrotoxicity after peptide radionuclide receptor therapy (PRRT). Cancer Biother Radiopharm. 2010 Oct; 25(5):507-9. PMID: 20849311.
      View in: PubMed
    4. DeNardo G, DeNardo S. Dose intensified molecular targeted radiotherapy for cancer-lymphoma as a paradigm. Semin Nucl Med. 2010 Mar; 40(2):136-44. PMID: 20113681.
      View in: PubMed
    5. DeNardo GL, DeNardo SJ. Health care in the United States in 2009: both sides of the "counter". Cancer Biother Radiopharm. 2009 Oct; 24(5):515-7. PMID: 19877880.
      View in: PubMed
    6. Balhorn R, Hok S, DeNardo S, Natarajan A, Mirick G, Corzett M, Denardo G. Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells. Mol Cancer. 2009 Apr 22; 8:25. PMID: 19383174.
      View in: PubMed
    7. DeNardo GL, Mirick GR, Hok S, DeNardo SJ, Beckett LA, Adamson GN, Balhorn RL. Molecular specific and cell selective cytotoxicity induced by a novel synthetic HLA-DR antibody mimic for lymphoma and leukemia. Int J Oncol. 2009 Feb; 34(2):511-6. PMID: 19148487.
      View in: PubMed
    8. DeNardo GL, DeNardo SJ. Update: Turning the heat on cancer. Cancer Biother Radiopharm. 2008 Dec; 23(6):671-80. PMID: 20443694.
      View in: PubMed
    9. DeNardo GL, Natarajan A, Hok S, Mirick G, DeNardo SJ, Corzett M, Sysko V, Lehmann J, Beckett L, Balhorn R. Nanomolecular HLA-DR10 antibody mimics: A potent system for molecular targeted therapy and imaging. Cancer Biother Radiopharm. 2008 Dec; 23(6):783-96. PMID: 20443696.
      View in: PubMed
    10. DeNardo G. Molecular imaging/therapy: it's only useful if it's useful--and available. J Nucl Med. 2008 Sep; 49(9):40N-42N, 44N. PMID: 18765580.
      View in: PubMed
    11. DeNardo GL, DeNardo SJ, Balhorn R. Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies? Cancer Biother Radiopharm. 2008 Aug; 23(4):383-97. PMID: 18771343.
      View in: PubMed
    12. Natarajan A, Kumaresan PR, Denardo SJ, Denardo GL, Mirick G, Lam KS. Development of TNKase-specific cleavable peptide-linked radioimmunoconjugates for radioimmunotherapy. Bioorg Med Chem Lett. 2008 Sep 01; 18(17):4802-5. PMID: 18701282.
      View in: PubMed
    13. Williams LE, DeNardo GL, Meredith RF. Targeted radionuclide therapy. Med Phys. 2008 Jul; 35(7):3062-8. PMID: 18697529.
      View in: PubMed
    14. Natarajan A, Gruettner C, Ivkov R, DeNardo GL, Mirick G, Yuan A, Foreman A, DeNardo SJ. NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics. Bioconjug Chem. 2008 Jun; 19(6):1211-8. PMID: 18517234.
      View in: PubMed
    15. Dadachova E, Revskaya E, Sesay MA, Damania H, Boucher R, Sellers RS, Howell RC, Burns L, Thornton GB, Natarajan A, Mirick GR, DeNardo SJ, DeNardo GL, Casadevall A. Pre-clinical evaluation and efficacy studies of a melanin-binding IgM antibody labeled with 188Re against experimental human metastatic melanoma in nude mice. Cancer Biol Ther. 2008 Jul; 7(7):1116-27. PMID: 18535406.
      View in: PubMed
    16. Lehmann J, Natarajan A, Denardo GL, Ivkov R, Foreman AR, Catapano C, Mirick G, Quang T, Gruettner C, Denardo SJ. Short communication: nanoparticle thermotherapy and external beam radiation therapy for human prostate cancer cells. Cancer Biother Radiopharm. 2008 Apr; 23(2):265-71. PMID: 18454696.
      View in: PubMed
    17. Natarajan A, Xiong CY, Gruettner C, DeNardo GL, DeNardo SJ. Development of multivalent radioimmunonanoparticles for cancer imaging and therapy. Cancer Biother Radiopharm. 2008 Feb; 23(1):82-91. PMID: 18298332.
      View in: PubMed
    18. DeNardo GL. The conundrum of personalized cancer management, drug development, and economics. Cancer Biother Radiopharm. 2007 Dec; 22(6):719-21. PMID: 18158762.
      View in: PubMed
    19. DeNardo GL, Hok S, Van Natarajan A, Cosman M, DeNardo SJ, Lightstone FC, Mirick GR, Yuan A, Perkins J, Sysko VV, Lehmann J, Balhorn RL. Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma. Int J Oncol. 2007 Oct; 31(4):729-40. PMID: 17786303.
      View in: PubMed
    20. Balhorn R, Hok S, Burke PA, Lightstone FC, Cosman M, Zemla A, Mirick G, Perkins J, Natarajan A, Corzett M, DeNardo SJ, Albrecht H, Gregg JP, DeNardo GL. Selective high-affinity ligand antibody mimics for cancer diagnosis and therapy: initial application to lymphoma/leukemia. Clin Cancer Res. 2007 Sep 15; 13(18 Pt 2):5621s-5628s. PMID: 17875798.
      View in: PubMed
    21. Schillaci O, DeNardo GL, DeNardo SJ, Goldstein DS, Kroger LA, O'Donnell RT, Lamborn KR. Effect of antilymphoma antibody, 131I-Lym-1, on peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma. Cancer Biother Radiopharm. 2007 Aug; 22(4):521-30. PMID: 17803447.
      View in: PubMed
    22. Albrecht H, Cosman M, Ngu-Schwemlein M, Corzett M, Curran KW, Dolan C, Fang X, DeNardo SJ, DeNardo GL, Balhorn R. Recombinant expression of the beta-subunit of HLA-DR10 for the selection of novel lymphoma targeting molecules. Cancer Biother Radiopharm. 2007 Aug; 22(4):531-42. PMID: 17803448.
      View in: PubMed
    23. Siantar CL, DeNardo GL, Lam K, Yuan A, Daly T, DeNardo SJ. Selecting an intervention time for intravascular enzymatic cleavage of peptide linkers to clear radioisotope from normal tissues. Cancer Biother Radiopharm. 2007 Aug; 22(4):556-63. PMID: 17803451.
      View in: PubMed
    24. DeNardo GL, Natarajan A, Hok S, Perkins J, Cosman M, DeNardo SJ, Lightstone FC, Mirick GR, Miers LA, Balhorn RL. Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma. J Nucl Med. 2007 Aug; 48(8):1338-47. PMID: 17631545.
      View in: PubMed
    25. Tobin E, Denardo G, Zhang N, Epstein AL, Liu C, Denardo S. Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell lines. Leuk Lymphoma. 2007 May; 48(5):944-56. PMID: 17487739.
      View in: PubMed
    26. Albrecht H, Denardo GL, Denardo SJ. Development of anti-MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers. Q J Nucl Med Mol Imaging. 2007 Dec; 51(4):304-13. PMID: 17464275.
      View in: PubMed
    27. Hok S, Natarajan A, Balhorn R, DeNardo SJ, DeNardo GL, Perkins J. Synthesis and radiolabeling of selective high-affinity ligands designed to target non-Hodgkin's lymphoma and leukemia. Bioconjug Chem. 2007 May-Jun; 18(3):912-21. PMID: 17373772.
      View in: PubMed
    28. DeNardo SJ, DeNardo GL, Natarajan A, Miers LA, Foreman AR, Gruettner C, Adamson GN, Ivkov R. Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice. J Nucl Med. 2007 Mar; 48(3):437-44. PMID: 17332622.
      View in: PubMed
    29. Liu H, Beckett LA, DeNardo GL. On the analysis of count data of birth-and-death process type: with application to molecularly targeted cancer therapy. Stat Med. 2007 Feb 28; 26(5):1114-35. PMID: 16755532.
      View in: PubMed
    30. Kumaresan PR, Natarajan A, Song A, Wang X, Liu R, DeNardo G, DeNardo S, Lam KS. Development of tissue plasminogen activator specific "on demand cleavable" (odc) linkers for radioimmunotherapy by screening one-bead-one-compound combinatorial peptide libraries. Bioconjug Chem. 2007 Jan-Feb; 18(1):175-82. PMID: 17226971.
      View in: PubMed
    31. West J, Perkins J, Hok S, Balhorn R, Lightstone FC, Cosman M, DeNardo SJ, DeNardo GL. Direct antilymphoma activity of novel, first-generation "antibody mimics" that bind HLA-DR10-positive non-Hodgkin's lymphoma cells. Cancer Biother Radiopharm. 2006 Dec; 21(6):645-54. PMID: 17257080.
      View in: PubMed
    32. Natarajan A, Du W, Xiong CY, DeNardo GL, DeNardo SJ, Gervay-Hague J. Construction of di-scFv through a trivalent alkyne-azide 1,3-dipolar cycloaddition. Chem Commun (Camb). 2007 Feb 21; (7):695-7. PMID: 17392953.
      View in: PubMed
    33. Lehmann J, DeNardo GL, Yuan A, Shen S, O'Donnell RT, Richman CM, DeNardo SJ. Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1192-8. PMID: 16965873.
      View in: PubMed
    34. Burke PA, Gregg JP, Bakhtiar B, Beckett LA, Denardo GL, Albrecht H, De Vere White RW, De Nardo SJ. Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules. Int J Oncol. 2006 Jul; 29(1):49-55. PMID: 16773184.
      View in: PubMed
    35. Xiong CY, Natarajan A, Shi XB, Denardo GL, Denardo SJ. Development of tumor targeting anti-MUC-1 multimer: effects of di-scFv unpaired cysteine location on PEGylation and tumor binding. Protein Eng Des Sel. 2006 Aug; 19(8):359-67. PMID: 16760193.
      View in: PubMed
    36. Denardo GL. Editorial: "right place, wrong place": extravasation of therapeutic drug for molecular targeted radiotherapy. Cancer Biother Radiopharm. 2006 Apr; 21(2):85-7. PMID: 16706628.
      View in: PubMed
    37. Azinovic I, DeNardo GL, Lamborn KR, Mirick G, Goldstein D, Bradt BM, DeNardo SJ. Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies. Cancer Immunol Immunother. 2006 Dec; 55(12):1451-8. PMID: 16496145.
      View in: PubMed
    38. Albrecht H, Denardo GL, Denardo SJ. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility. J Immunol Methods. 2006 Mar 20; 310(1-2):100-16. PMID: 16499921.
      View in: PubMed
    39. DeNardo GL, Sysko VV, DeNardo SJ. Cure of incurable lymphoma. Int J Radiat Oncol Biol Phys. 2006; 66(2 Suppl):S46-56. PMID: 16979440.
      View in: PubMed
    40. DeNardo SJ, Denardo GL. Targeted radionuclide therapy for solid tumors: an overview. Int J Radiat Oncol Biol Phys. 2006; 66(2 Suppl):S89-95. PMID: 16979448.
      View in: PubMed
    41. Shen S, DeNardo GL, Yuan A, Hartmann-Siantar C, O'Donnell RT, DeNardo SJ. Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibody. Cancer Biother Radiopharm. 2005 Dec; 20(6):662-70. PMID: 16398618.
      View in: PubMed
    42. Miers L, DeNardo SJ, Lamborn K, DeNardo GL. Implantation of different malignant human cell lines in an athymic mouse does not alter success and growth rates of either xenograft. Cancer Biother Radiopharm. 2005 Dec; 20(6):614-9. PMID: 16398613.
      View in: PubMed
    43. DeNardo GL, Tobin E, Chan K, Bradt BM, DeNardo SJ. Direct antilymphoma effects on human lymphoma cells of monotherapy and combination therapy with CD20 and HLA-DR antibodies and 90Y-labeled HLA-DR antibodies. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7075s-7079s. PMID: 16203805.
      View in: PubMed
    44. DeNardo SJ, DeNardo GL, Miers LA, Natarajan A, Foreman AR, Gruettner C, Adamson GN, Ivkov R. Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7087s-7092s. PMID: 16203807.
      View in: PubMed
    45. DeNardo SJ, Richman CM, Albrecht H, Burke PA, Natarajan A, Yuan A, Gregg JP, O'Donnell RT, DeNardo GL. Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7187s-7194s. PMID: 16203820.
      View in: PubMed
    46. Ivkov R, DeNardo SJ, Daum W, Foreman AR, Goldstein RC, Nemkov VS, DeNardo GL. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7093s-7103s. PMID: 16203808.
      View in: PubMed
    47. Miers L, Lamborn K, Yuan A, Richman C, Natarajan A, DeNardo S, DeNardo G. Does paclitaxel (Taxol) given after (111)In-labeled monoclonal antibodies increase tumor-cumulated activity in epithelial cancers? Clin Cancer Res. 2005 Oct 01; 11(19 Pt 2):7158s-7163s. PMID: 16203816.
      View in: PubMed
    48. Richman CM, Denardo SJ, O'Donnell RT, Yuan A, Shen S, Goldstein DS, Tuscano JM, Wun T, Chew HK, Lara PN, Kukis DL, Natarajan A, Meares CF, Lamborn KR, DeNardo GL. High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody. Clin Cancer Res. 2005 Aug 15; 11(16):5920-7. PMID: 16115934.
      View in: PubMed
    49. DeNardo GL. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs). Semin Nucl Med. 2005 Jul; 35(3):202-11. PMID: 16098294.
      View in: PubMed
    50. Shen S, DeNardo SJ, Richman CM, Yuan A, Siantar CH, O'Donnell RT, Kroger LA, DeNardo GL. Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry. J Nucl Med. 2005 Jun; 46(6):1034-41. PMID: 15937317.
      View in: PubMed
    51. Lehmann J, Hartmann Siantar C, Wessol DE, Wemple CA, Nigg D, Cogliati J, Daly T, Descalle MA, Flickinger T, Pletcher D, Denardo G. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system. Phys Med Biol. 2005 Mar 07; 50(5):947-58. PMID: 15798267.
      View in: PubMed
    52. DeNardo GL. Concepts in radioimmunotherapy and immunotherapy: Radioimmunotherapy from a Lym-1 perspective. Semin Oncol. 2005 Feb; 32(1 Suppl 1):S27-35. PMID: 15786023.
      View in: PubMed
    53. Natarajan A, Xiong CY, Albrecht H, DeNardo GL, DeNardo SJ. Characterization of site-specific ScFv PEGylation for tumor-targeting pharmaceuticals. Bioconjug Chem. 2005 Jan-Feb; 16(1):113-21. PMID: 15656582.
      View in: PubMed
    54. Wemple CA, Wessol DE, Nigg DW, Cogliati JJ, Milvich M, Fredrickson CM, Perkins M, Harkin GJ, Hartmann-Siantar CL, Lehmann J, Flickinger T, Pletcher D, Yuan A, DeNardo GL. MINERVA: a multi-modality plugin-based radiation therapy treatment planning system. Radiat Prot Dosimetry. 2005; 116(1-4 Pt 2):202-7. PMID: 16604627.
      View in: PubMed
    55. Mirick GR, Bradt BM, Denardo SJ, Denardo GL. A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words. Q J Nucl Med Mol Imaging. 2004 Dec; 48(4):251-7. PMID: 15640788.
      View in: PubMed
    56. Wessels BW, Bolch WE, Bouchet LG, Breitz HB, Denardo GL, Meredith RF, Stabin MG, Sgouros G. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison. J Nucl Med. 2004 Oct; 45(10):1725-33. PMID: 15471841.
      View in: PubMed
    57. DeNardo GL. New directions in radioimmunotherapy of non-Hodgkin's lymphoma. Clin Lymphoma. 2004 Oct; 5 Suppl 1:S4. PMID: 15498148.
      View in: PubMed
    58. Liu C, DeNardo G, Tobin E, DeNardo S. Antilymphoma effects of anti-HLA-DR and CD20 monoclonal antibodies (Lym-1 and Rituximab) on human lymphoma cells. Cancer Biother Radiopharm. 2004 Oct; 19(5):545-61. PMID: 15650447.
      View in: PubMed
    59. DeNardo GL, Kennel SJ, Siegel JA, Denardo SJ. Radiometals as payloads for radioimmunotherapy for lymphoma. Clin Lymphoma. 2004 Oct; 5 Suppl 1:S5-10. PMID: 15498149.
      View in: PubMed
    60. DeNardo GL, DeNardo SJ. Evaluation of a cathepsin-cleavable peptide linked radioimmunoconjugate of a panadenocarcinoma MAb, m170, in mice and patients. Cancer Biother Radiopharm. 2004 Feb; 19(1):85-92. PMID: 15068616.
      View in: PubMed
    61. Albrecht H, Burke PA, Natarajan A, Xiong CY, Kalicinsky M, DeNardo GL, DeNardo SJ. Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand. Bioconjug Chem. 2004 Jan-Feb; 15(1):16-26. PMID: 14733579.
      View in: PubMed
    62. Juweid M, DeNardo GL, Graham M, Vose J. Radioimmunotherapy: a novel treatment modality for B-cell non-Hodgkin's lymphoma. Cancer Biother Radiopharm. 2003 Oct; 18(5):673-4. PMID: 14629816.
      View in: PubMed
    63. DeNardo GL, Mirick GR, Kroger LA, Bradt BM, Lamborn KR, DeNardo SJ. Characterization of human IgG antimouse antibody in patients with B-cell malignancies. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):4013S-21S. PMID: 14506202.
      View in: PubMed
    64. Winthrop MD, DeNardo SJ, Albrecht H, Mirick GR, Kroger LA, Lamborn KR, Venclovas C, Colvin ME, Burke PA, DeNardo GL. Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3845S-53S. PMID: 14506182.
      View in: PubMed
    65. DeNardo SJ, Yao Z, Lam KS, Song A, Burke PA, Mirick GR, Lamborn KR, O'Donnell RT, DeNardo GL. Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3854S-64S. PMID: 14506183.
      View in: PubMed
    66. DeNardo GL, DeNardo SJ, Peterson JJ, Miers LA, Lam KS, Hartmann-Siantar C, Lamborn KR. Preclinical evaluation of cathepsin-degradable peptide linkers for radioimmunoconjugates. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3865S-72S. PMID: 14506184.
      View in: PubMed
    67. DeNardo SJ, DeNardo GL, Yuan A, Richman CM, O'Donnell RT, Lara PN, Kukis DL, Natarajan A, Lamborn KR, Jacobs F, Siantar CL. Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):3938S-44S. PMID: 14506192.
      View in: PubMed
    68. Bradt BM, DeNardo SJ, Mirick GR, DeNardo GL. Documentation of idiotypic cascade after Lym-1 radioimmunotherapy in a patient with non-Hodgkin's lymphoma: basis for extended survival? Clin Cancer Res. 2003 Sep 01; 9(10 Pt 2):4007S-12S. PMID: 14506201.
      View in: PubMed
    69. Hartmann Siantar CL, DeNardo GL, DeNardo SJ. Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapy. J Nucl Med. 2003 Aug; 44(8):1322-9. PMID: 12902424.
      View in: PubMed
    70. DeNardo G, Yuan A, Goldstein D, Richman C, O'Donnell R, Shen S, Hartmann Siantar C, DeNardo S. Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbs. Cancer Biother Radiopharm. 2003 Apr; 18(2):231-7. PMID: 12804049.
      View in: PubMed
    71. DeNardo GL, Bradt BM, Mirick GR, DeNardo S. Human antiglobulin response to foreign antibodies: therapeutic benefit? Cancer Immunol Immunother. 2003 May; 52(5):309-16. PMID: 12700946.
      View in: PubMed
    72. Descalle MA, Hartmann Siantar CL, Dauffy L, Nigg DW, Wemple CA, Yuan A, DeNardo GL. Application of MINERVA Monte Carlo simulations to targeted radionuclide therapy. Cancer Biother Radiopharm. 2003 Feb; 18(1):71-9. PMID: 12667310.
      View in: PubMed
    73. Tuscano JM, O'Donnell RT, Miers LA, Kroger LA, Kukis DL, Lamborn KR, Tedder TF, DeNardo GL. Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts. Blood. 2003 May 01; 101(9):3641-7. PMID: 12511412.
      View in: PubMed
    74. DeNardo GL, Oldham RK. Year 2002: the best year yet for CB&R. Cancer Biother Radiopharm. 2002 Dec; 17(6):599-600. PMID: 12537663.
      View in: PubMed
    75. Burke PA, DeNardo SJ, Miers LA, Lamborn KR, Matzku S, DeNardo GL. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts. Cancer Res. 2002 Aug 01; 62(15):4263-72. PMID: 12154028.
      View in: PubMed
    76. Siantar CH, Vetter K, DeNardo GL, DeNardo SJ. Treatment planning for molecular targeted radionuclide therapy. Cancer Biother Radiopharm. 2002 Jun; 17(3):267-80. PMID: 12136519.
      View in: PubMed
    77. Burke PA, DeNardo SJ, Miers LA, Kukis DL, DeNardo GL. Combined modality radioimmunotherapy. Promise and peril. Cancer. 2002 Feb 15; 94(4 Suppl):1320-31. PMID: 11877763.
      View in: PubMed
    78. DeNardo GL, Schlom J, Buchsbaum DJ, Meredith RF, O'Donoghue JA, Sgouros G, Humm JL, DeNardo SJ. Rationales, evidence, and design considerations for fractionated radioimmunotherapy. Cancer. 2002 Feb 15; 94(4 Suppl):1332-48. PMID: 11877764.
      View in: PubMed
    79. DeNardo GL, Siantar CL, DeNardo SJ. Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy. Cancer Biother Radiopharm. 2002 Feb; 17(1):107-18. PMID: 11915167.
      View in: PubMed
    80. O'Donnell RT, DeNardo SJ, Miers LA, Lamborn KR, Kukis DL, DeNardo GL, Meyers FJ. Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6. Prostate. 2002 Jan 01; 50(1):27-37. PMID: 11757033.
      View in: PubMed
    81. DeNardo DG, Xiong CY, Shi XB, DeNardo GL, DeNardo SJ. Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: bispecific antibodies for pretargeted radioimmunotherapy. Cancer Biother Radiopharm. 2001 Dec; 16(6):525-35. PMID: 11789029.
      View in: PubMed
    82. DeNardo GL, DeNardo SJ, Kukis DL, O'Donnell RT, Shen S, Mirick GR, Meares CF. Metabolite production in patients with lymphoma after radiometal-labeled antibody administration. J Nucl Med. 2001 Sep; 42(9):1324-33. PMID: 11535720.
      View in: PubMed
    83. DeNardo GL, Juweid ME, White CA, Wiseman GA, DeNardo SJ. Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing. Crit Rev Oncol Hematol. 2001 Jul-Aug; 39(1-2):203-18. PMID: 11418317.
      View in: PubMed
    84. O'Donnell RT, DeNardo SJ, Yuan A, Shen S, Richman CM, Lara PN, Griffith IJ, Goldstein DS, Kukis DL, Martinez GS, Mirick GR, DeNardo GL, Meyers FJ. Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer. Clin Cancer Res. 2001 Jun; 7(6):1561-8. PMID: 11410491.
      View in: PubMed
    85. Kroger LA, DeNardo GL, Gumerlock PH, Xiong CY, Winthrop MD, Shi XB, Mack PC, Leshchinsky T, DeNardo SJ. Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapy. Cancer Biother Radiopharm. 2001 Jun; 16(3):213-25. PMID: 11471486.
      View in: PubMed
    86. DeNardo GL, O'Donnell RT, DeNardo SJ. Radiolabeled anti-lymphoma antibodies. Cancer Chemother Biol Response Modif. 2001; 19:297-308. PMID: 11686019.
      View in: PubMed
    87. DeNardo GL, DeNardo SJ, Wessels BW, Kukis DL, Miyao N, Yuan A. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis. Cancer Biother Radiopharm. 2000 Dec; 15(6):547-60. PMID: 11190487.
      View in: PubMed
    88. DeNardo GL, DeNardo SJ, O'Donnell RT, Kroger LA, Kukis DL, Meares CF, Goldstein DS, Shen S. Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma. Clin Lymphoma. 2000 Sep; 1(2):118-26. PMID: 11707820.
      View in: PubMed
    89. O'Donnell RT, Shen S, Denardo SJ, Wun T, Kukis DL, Goldstein DS, Denardo GL. A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma. Anticancer Res. 2000 Sep-Oct; 20(5C):3647-55. PMID: 11268433.
      View in: PubMed
    90. Winthrop MD, Denardo GL, Denardo SJ. Antibody phage display applications for nuclear medicine imaging and therapy. Q J Nucl Med. 2000 Sep; 44(3):284-95. PMID: 11105591.
      View in: PubMed
    91. O'Donnell RT, DeNardo SJ, DeNardo GL, Miers L, Lamborn KR, Kukis DL, Meyers FJ. Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice. Prostate. 2000 Aug 01; 44(3):187-92. PMID: 10906734.
      View in: PubMed
    92. DeNardo GL, O'Donnell RT, Shen S, Kroger LA, Yuan A, Meares CF, Kukis DL, DeNardo SJ. Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma. J Nucl Med. 2000 May; 41(5):952-8. PMID: 10809213.
      View in: PubMed
    93. DeNardo GL. When is too much too much and yet not enough? Alas, a plethora of opportunities but where's the beef? J Nucl Med. 2000 Mar; 41(3):470-3. PMID: 10716321.
      View in: PubMed
    94. DeNardo SJ, Burke PA, Leigh BR, O'Donnell RT, Miers LA, Kroger LA, Goodman SL, Matzku S, Jonczyk A, Lamborn KR, DeNardo GL. Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy. Cancer Biother Radiopharm. 2000 Feb; 15(1):71-9. PMID: 10740655.
      View in: PubMed
    95. O'Donnell RT, DeNardo GL, Kukis DL, Lamborn KR, Shen S, Yuan A, Goldstein DS, Carr CE, Mirick GR, DeNardo SJ. A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma. J Nucl Med. 1999 Dec; 40(12):2014-20. PMID: 10616879.
      View in: PubMed
    96. Shen S, DeNardo GL, Sgouros G, O'Donnell RT, DeNardo SJ. Practical determination of patient-specific marrow dose using radioactivity concentration in blood and body. J Nucl Med. 1999 Dec; 40(12):2102-6. PMID: 10616892.
      View in: PubMed
    97. Silverman S, DeNardo GL, Siegel E. Determination of spleen size by scintigraphy. Cancer Biother Radiopharm. 1999 Oct; 14(5):407-11. PMID: 10850326.
      View in: PubMed
    98. DeNardo GL. Tribute to David A. Goodwin and Claude F. Meares, recipients of the Immunomedics Science Award. Clin Cancer Res. 1999 Oct; 5(10 Suppl):2992s-2993s. PMID: 10541332.
      View in: PubMed
    99. DeNardo SJ, DeNardo GL, DeNardo DG, Xiong CY, Shi XB, Winthrop MD, Kroger LA, Carter P. Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3213s-3218s. PMID: 10541366.
      View in: PubMed
    100. Kroger LA, DeNardo SJ, DeNardo GL, Xiong CY, Winthrop MD, Gumerlock PH. Effect of 67Cu-2IT-BAT-Lym-1 therapy on BCL-2 gene and protein expression in a lymphoma mouse model. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3010s-3014s. PMID: 10541336.
      View in: PubMed
    101. Richman CM, DeNardo SJ, O'Donnell RT, Goldstein DS, Shen S, Kukis DL, Kroger LA, Yuan A, Boniface GR, Griffith IJ, DeNardo GL. Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3243s-3248s. PMID: 10541370.
      View in: PubMed
    102. O'Donnell RT, DeNardo GL, Kukis DL, Lamborn KR, Shen S, Yuan A, Goldstein DS, Mirick GR, DeNardo SJ. 67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3330s-3336s. PMID: 10541382.
      View in: PubMed
    103. Kukis DL, DeNardo SJ, Mills SL, Shen S, O'Donnell RT, DeNardo GL. Stability of monoclonal antibodies, Lym-1 and ChL6, and 2IT-BAD-Lym-1 immunoconjugate with ultra freezer storage. Cancer Biother Radiopharm. 1999 Oct; 14(5):363-9. PMID: 10850321.
      View in: PubMed
    104. DeNardo SJ, Kroger LA, DeNardo GL. A new era for radiolabeled antibodies in cancer? Curr Opin Immunol. 1999 Oct; 11(5):563-9. PMID: 10508716.
      View in: PubMed
    105. Winthrop MD, DeNardo SJ, DeNardo GL. Development of a hyperimmune anti-MUC-1 single chain antibody fragments phage display library for targeting breast cancer. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3088s-3094s. PMID: 10541348.
      View in: PubMed
    106. DeNardo GL, O'Donnell RT, Kroger LA, Richman CM, Goldstein DS, Shen S, DeNardo SJ. Strategies for developing effective radioimmunotherapy for solid tumors. Clin Cancer Res. 1999 Oct; 5(10 Suppl):3219s-3223s. PMID: 10541367.
      View in: PubMed
    107. Mirick GR, O'Donnell RT, DeNardo SJ, Shen S, Meares CF, DeNardo GL. Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients. Nucl Med Biol. 1999 Oct; 26(7):841-5. PMID: 10628566.
      View in: PubMed
    108. Macey DJ, DeNardo GL, DeNardo SJ. Planar gamma camera quantitation of 123I, 99mTc or 111In in the liver and spleen of an abdominal phantom. Cancer Biother Radiopharm. 1999 Aug; 14(4):299-306. PMID: 10850316.
      View in: PubMed
    109. DeNardo GL, DeNardo SJ, Shen S, DeNardo DA, Mirick GR, Macey DJ, Lamborn KR. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia. J Nucl Med. 1999 Aug; 40(8):1317-26. PMID: 10450684.
      View in: PubMed
    110. Rose LM, Deng CT, Scott SL, Xiong CY, Lamborn KR, Gumerlock PH, DeNardo GL, Meares CF. Critical Lym-1 binding residues on polymorphic HLA-DR molecules. Mol Immunol. 1999 Aug; 36(11-12):789-97. PMID: 10593517.
      View in: PubMed
    111. DeNardo GL. About the old and the new: gallium-67 scintigraphy to rituximab for lymphoma. Cancer Biother Radiopharm. 1999 Aug; 14(4):235-6. PMID: 10850308.
      View in: PubMed
    112. O'Donnell RT, Leigh BR, Christensen SD, Goldstein DS, Kukis DL, Shen S, Yuan A, DeNardo DA, Kroger LA, DeNardo GL. Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma. Cancer Biother Radiopharm. 1999 Jun; 14(3):167-76. PMID: 10850301.
      View in: PubMed
    113. Leigh BR, Burke PA, Hong AM, O'Donnell RT, Howell LP, Miers LA, DeNardo GL, DeNardo SJ. Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapy. Cancer Biother Radiopharm. 1999 Apr; 14(2):113-9. PMID: 10850294.
      View in: PubMed
    114. Wilder RB, Shen S, DeNardo GL. Dosimetry for radioimmunotherapy: a rapidly evolving field. Cancer Biother Radiopharm. 1999 Apr; 14(2):67-70. PMID: 10850289.
      View in: PubMed
    115. DeNardo GL, Oldham RK. "Historical Vignettes". Cancer Biother Radiopharm. 1999 Apr; 14(2):65-6. PMID: 10917743.
      View in: PubMed
    116. Shi XB, Gumerlock PH, Kroger L, DeNardo GL, DeNardo SJ. Efficient recombination of Lym-1 scFv gene using multiple doubly-restricted DNA fragments. Cancer Biother Radiopharm. 1999 Apr; 14(2):139-43. PMID: 10850298.
      View in: PubMed
    117. DeNardo GL, Kukis DL, Shen S, DeNardo DA, Meares CF, DeNardo SJ. 67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma. Clin Cancer Res. 1999 Mar; 5(3):533-41. PMID: 10100704.
      View in: PubMed
    118. DeNardo SJ, DeNardo GL, Kukis DL, Shen S, Kroger LA, DeNardo DA, Goldstein DS, Mirick GR, Salako Q, Mausner LF, Srivastava SC, Meares CF. 67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma. J Nucl Med. 1999 Feb; 40(2):302-10. PMID: 10025839.
      View in: PubMed
    119. DeNardo SJ, DeNardo GL, Brush J, Carter P. Phage library-derived human anti-TETA and anti-DOTA ScFv for pretargeting RIT. Hybridoma. 1999 Feb; 18(1):13-21. PMID: 10211783.
      View in: PubMed
    120. DeNardo GL, O'Donnell RT, Rose LM, Mirick GR, Kroger LA, DeNardo SJ. Milestones in the development of Lym-1 therapy. Hybridoma. 1999 Feb; 18(1):1-11. PMID: 10211782.
      View in: PubMed
    121. Kukis DL, DeNardo SJ, DeNardo GL, O'Donnell RT, Meares CF. Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates. J Nucl Med. 1998 Dec; 39(12):2105-10. PMID: 9867151.
      View in: PubMed
    122. DeNardo GL. Bone pain palliation. Cancer Biother Radiopharm. 1998 Dec; 13(6):407-11. PMID: 10851433.
      View in: PubMed
    123. Denardo SJ, Richman CM, Kukis DL, Shen S, Lamborn KR, Miers LA, Kroger LA, Perez EA, Denardo GL. Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol. Anticancer Res. 1998 Nov-Dec; 18(6A):4011-8. PMID: 9891439.
      View in: PubMed
    124. O'Donnell RT, DeNardo SJ, Shi XB, Mirick GR, DeNardo GL, Kroger LA, Meyers FJ. L6 monoclonal antibody binds prostate cancer. Prostate. 1998 Oct 01; 37(2):91-7. PMID: 9759703.
      View in: PubMed
    125. DeNardo GL, Kroger LA, Meares CF, Richman CM, Salako Q, Shen S, Lamborn KR, Peterson JJ, Miers LA, Zhong GR, DeNardo SJ. Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts. Clin Cancer Res. 1998 Oct; 4(10):2483-90. PMID: 9796981.
      View in: PubMed
    126. O'Donnell RT, DeNardo SJ, Miers LA, Kukis DL, Mirick GR, Kroger LA, DeNardo GL. Combined modality radioimmunotherapy with Taxol and 90Y-Lym-1 for Raji lymphoma xenografts. Cancer Biother Radiopharm. 1998 Oct; 13(5):351-61. PMID: 10851425.
      View in: PubMed
    127. DeNardo GL, DeNardo SJ, Goldstein DS, Kroger LA, Lamborn KR, Levy NB, McGahan JP, Salako Q, Shen S, Lewis JP. Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma. J Clin Oncol. 1998 Oct; 16(10):3246-56. PMID: 9779698.
      View in: PubMed
    128. DeNardo GL. Biotherapy of cancer marches on! Cancer Biother Radiopharm. 1998 Oct; 13(5):335-6. PMID: 10851423.
      View in: PubMed
    129. DeNardo GL, O'Donnell RT, Oldham RK, DeNardo SJ. A revolution in the treatment of non-Hodgkin's lymphoma. Cancer Biother Radiopharm. 1998 Aug; 13(4):213-23. PMID: 10850358.
      View in: PubMed
    130. DeNardo GL, DeNardo SJ, Lamborn KR, Goldstein DS, Levy NB, Lewis JP, O'Grady LF, Raventos A, Kroger LA, Macey DJ, McGahan JP, Mills SL, Shen S. Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibody. Cancer Biother Radiopharm. 1998 Aug; 13(4):239-54. PMID: 10850360.
      View in: PubMed
    131. Shen S, DeNardo GL, Jones TD, Wilder RB, O'Donnell RT, DeNardo SJ. A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapy. J Nucl Med. 1998 Jul; 39(7):1223-9. PMID: 9669399.
      View in: PubMed
    132. Denardo GL, Denardo SJ, Kukis DL, O'Donnell RT, Shen S, Goldstein DS, Kroger LA, Salako Q, Denardo DA, Mirick GR, Mausner LF, Srivastava SC, Meares CF. Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study. Anticancer Res. 1998 Jul-Aug; 18(4B):2779-88. PMID: 9713461.
      View in: PubMed
    133. DeNardo SJ, Kukis DL, Miers LA, Winthrop MD, Kroger LA, Salako Q, Shen S, Lamborn KR, Gumerlock PH, Meares CF, DeNardo GL. Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts. J Nucl Med. 1998 May; 39(5):842-9. PMID: 9591587.
      View in: PubMed
    134. DeNardo GL, Shen S, DeNardo SJ, Liao SQ, Lamborn KR, DeNardo DA, Yuan A. Quantification of iodine-131 in tumors using a threshold based on image contrast. Eur J Nucl Med. 1998 May; 25(5):497-502. PMID: 9575245.
      View in: PubMed
    135. Feng X, Pak RH, Kroger LA, Moran JK, DeNardo DG, Meares CF, DeNardo GL, DeNardo SJ. New anti-Cu-TETA and anti-Y-DOTA monoclonal antibodies for potential use in the pre-targeted delivery of radiopharmaceuticals to tumor. Hybridoma. 1998 Apr; 17(2):125-32. PMID: 9627052.
      View in: PubMed
    136. DeNardo SJ, Kroger LA, MacKenzie MR, Mirick GR, Shen S, DeNardo GL. Prolonged survival associated with immune response in a patient treated with Lym-1 mouse monoclonal antibody. Cancer Biother Radiopharm. 1998 Feb; 13(1):1-12. PMID: 10850337.
      View in: PubMed
    137. Richman CM, Schuermann TC, Wun T, Malik R, O'Donnell RT, DeNardo GL, DeNardo SJ. Peripheral blood stem cell mobilization for hematopoietic support of radioimmunotherapy in patients with breast carcinoma. Cancer. 1997 Dec 15; 80(12 Suppl):2728-32. PMID: 9406731.
      View in: PubMed
    138. DeNardo DA, DeNardo GL, O'Donnell RT, Lim SM, Shen S, Yuan A, DeNardo SJ. Imaging for improved prediction of myelotoxicity after radioimmunotherapy. Cancer. 1997 Dec 15; 80(12 Suppl):2558-66. PMID: 9406710.
      View in: PubMed
    139. DeNardo SJ, Kroger LA, Lamborn KR, Miers LA, O'Donnell RT, Kukis DL, Richman CM, DeNardo GL. Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma. Cancer. 1997 Dec 15; 80(12 Suppl):2583-90. PMID: 9406713.
      View in: PubMed
    140. Shen S, DeNardo GL, O'Donnell RT, Yuan A, DeNardo DA, DeNardo SJ. Impact of splenomegaly on therapeutic response and I-131-LYM-1 dosimetry in patients with B-lymphocytic malignancies. Cancer. 1997 Dec 15; 80(12 Suppl):2553-7. PMID: 9406709.
      View in: PubMed
    141. DeNardo GL, Kukis DL, DeNardo SJ, Shen S, Mausner LF, O'Donnell RT, Lamborn KR, Meyers FJ, Srivastava SC, Miers LA. Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2. Cancer. 1997 Dec 15; 80(12 Suppl):2576-82. PMID: 9406712.
      View in: PubMed
    142. DeNardo GL, Lamborn KR, Goldstein DS, Kroger LA, DeNardo SJ. Increased survival associated with radiolabeled Lym-1 therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Cancer. 1997 Dec 15; 80(12 Suppl):2706-11. PMID: 9406728.
      View in: PubMed
    143. DeNardo GL. Tribute to Ralph A. Reisfeld, Ph.D. Cancer. 1997 Dec 15; 80(12 Suppl):2345-6. PMID: 9406681.
      View in: PubMed
    144. Lim S, DeNardo GL, DeNardo DA, O'Donnell RT, Yuan A, DeNardo SJ. Prediction of myelotoxicity using semi-quantitative marrow image scores. J Nucl Med. 1997 Nov; 38(11):1749-53. PMID: 9374345.
      View in: PubMed
    145. Lim SM, DeNardo GL, DeNardo DA, Shen S, Yuan A, O'Donnell RT, DeNardo SJ. Prediction of myelotoxicity using radiation doses to marrow from body, blood and marrow sources. J Nucl Med. 1997 Sep; 38(9):1374-8. PMID: 9293790.
      View in: PubMed
    146. DeNardo SJ, Kramer EL, O'Donnell RT, Richman CM, Salako QA, Shen S, Noz M, Glenn SD, Ceriani RL, DeNardo GL. Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial. J Nucl Med. 1997 Aug; 38(8):1180-5. PMID: 9255145.
      View in: PubMed
    147. Lamborn KR, DeNardo GL, DeNardo SJ, Goldstein DS, Shen S, Larkin EC, Kroger LA. Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies. Clin Cancer Res. 1997 Aug; 3(8):1253-60. PMID: 9815807.
      View in: PubMed
    148. Shen S, DeNardo GL, Macey DJ, O'Donnell RT, Yuan A, DeNardo DA, DeNardo SJ. Practical determination of organ S values for individual patients for therapy. Nucl Med Biol. 1997 Jul; 24(5):447-9. PMID: 9290081.
      View in: PubMed
    149. Denardo SJ, O'Grady LF, Richman CM, Goldstein DS, O'Donnell RT, Denardo DA, Kroger LA, Lamborn KR, Hellström KE, Hellström I, Denardo GL. Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody. Anticancer Res. 1997 May-Jun; 17(3B):1745-51. PMID: 9179228.
      View in: PubMed
    150. Denardo SJ, Richman CM, Goldstein DS, Shen S, Salako Q, Kukis DL, Meares CF, Yuan A, Welborn JL, Denardo GL. Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer. Anticancer Res. 1997 May-Jun; 17(3B):1735-44. PMID: 9179227.
      View in: PubMed
    151. DeNardo SJ, Kukis DL, Kroger LA, O'Donnell RT, Lamborn KR, Miers LA, DeNardo DG, Meares CF, DeNardo GL. Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts. Proc Natl Acad Sci U S A. 1997 Apr 15; 94(8):4000-4. PMID: 9108094.
      View in: PubMed
    152. Morris G, DeNardo SJ, DeNardo GL, Leshchinsky T, Wu B, Mack PC, Winthrop MD, Gumerlock PH. Decreased C-MYC and BCL2 expression correlates with methylprednisolone-mediated inhibition of Raji lymphoma growth. Biochem Mol Med. 1997 Apr; 60(2):108-15. PMID: 9169090.
      View in: PubMed
    153. DeNardo GL, Kukis DL, Shen S, Mausner LF, Meares CF, Srivastava SC, Miers LA, DeNardo SJ. Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji). Clin Cancer Res. 1997 Jan; 3(1):71-9. PMID: 9815540.
      View in: PubMed
    154. Shen S, DeNardo GL, DeNardo SJ, Yuan A, DeNardo DA, Lamborn KR. Reproducibility of operator processing for radiation dosimetry. Nucl Med Biol. 1997 Jan; 24(1):77-83. PMID: 9080478.
      View in: PubMed
    155. Zuckier LS, DeNardo GL. Trials and tribulations: oncological antibody imaging comes to the fore. Semin Nucl Med. 1997 Jan; 27(1):10-29. PMID: 9122720.
      View in: PubMed
    156. DeNardo DA, DeNardo GL, Yuan A, Shen S, DeNardo SJ, Macey DJ, Lamborn KR, Mahe M, Groch MW, Erwin WD. Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodies. J Nucl Med. 1996 Dec; 37(12):1970-5. PMID: 8970516.
      View in: PubMed
    157. Rose LM, Gunasekera AH, DeNardo SJ, DeNardo GL, Meares CF. Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10. Cancer Immunol Immunother. 1996 Sep; 43(1):26-30. PMID: 8917632.
      View in: PubMed
    158. Wilder RB, DeNardo GL, Sheri S, Fowler JF, Wessels BW, DeNardo SJ. Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy. Eur J Nucl Med. 1996 Aug; 23(8):953-7. PMID: 8753685.
      View in: PubMed
    159. DeNardo SJ, O'Donnell RT, DeNardo GL. Potential use of amino acid cocktails to reduce renal tubular reabsorption of radioconjugates. J Nucl Med. 1996 May; 37(5):837-8. PMID: 8965156.
      View in: PubMed
    160. Erwin WD, Groch MW, Macey DJ, DeNardo GL, DeNardo SJ, Shen S. A radioimmunoimaging and MIRD dosimetry treatment planning program for radioimmunotherapy. Nucl Med Biol. 1996 May; 23(4):525-32. PMID: 8832711.
      View in: PubMed
    161. Wilder RB, DeNardo GL, DeNardo SJ. Radioimmunotherapy: recent results and future directions. J Clin Oncol. 1996 Apr; 14(4):1383-400. PMID: 8648397.
      View in: PubMed
    162. DeNardo GL, Mirick GR, Kroger LA, O'Donnell RT, Meares CF, DeNardo SJ. Antibody responses to macrocycles in lymphoma. J Nucl Med. 1996 Mar; 37(3):451-6. PMID: 8772643.
      View in: PubMed
    163. DeNardo GL, Kukis DL, Shen S, DeNardo SJ. Accurate measurement of copper-67 in the presence of copper-64 contaminant using a dose calibrator. J Nucl Med. 1996 Feb; 37(2):302-6. PMID: 8667066.
      View in: PubMed
    164. Shen S, DeNardo GL, DeNardo SJ, Salako Q, Morris G, Banks D, Yuan A, DeNardo DA. Dosimetric evaluation of copper-64 in copper-67-2IT-BAT-Lym-1 for radioimmunotherapy. J Nucl Med. 1996 Jan; 37(1):146-50. PMID: 8543984.
      View in: PubMed
    165. Richman CM, DeNardo SJ, O'Grady LF, DeNardo GL. Radioimmunotherapy for breast cancer using escalating fractionated doses of 131I-labeled chimeric L6 antibody with peripheral blood progenitor cell transfusions. Cancer Res. 1995 Dec 01; 55(23 Suppl):5916s-5920s. PMID: 7493370.
      View in: PubMed
    166. DeNardo SJ, Gumerlock PH, Winthrop MD, Mack PC, Chi SG, Lamborn KR, Shen S, Miers LA, deVere White RW, DeNardo GL. Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression. Cancer Res. 1995 Dec 01; 55(23 Suppl):5837s-5841s. PMID: 7493356.
      View in: PubMed
    167. DeNardo GL, Lamborn KR, DeNardo SJ, Goldstein DS, Dolber-Smith EG, Kroger LA, Larkin EC, Shen S. Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies. Cancer Res. 1995 Dec 01; 55(23 Suppl):5893s-5898s. PMID: 7493366.
      View in: PubMed
    168. Howell LP, DeNardo SJ, Levy NB, Lund J, DeNardo GL. Immunohistochemical staining of metastatic ductal carcinomas of the breast by monoclonal antibodies used in imaging and therapy: A comparative study. Int J Biol Markers. 1995 Jul-Sep; 10(3):129-35. PMID: 8551054.
      View in: PubMed
    169. Breitz HB, Durham JS, Fisher DR, Weiden PL, DeNardo GL, Goodgold HM, Nelp WB. Pharmacokinetics and normal organ dosimetry following intraperitoneal rhenium-186-labeled monoclonal antibody. J Nucl Med. 1995 May; 36(5):754-61. PMID: 7738644.
      View in: PubMed
    170. DeNardo SJ, Zhong GR, Salako Q, Li M, DeNardo GL, Meares CF. Pharmacokinetics of chimeric L6 conjugated to indium-111- and yttrium-90-DOTA-peptide in tumor-bearing mice. J Nucl Med. 1995 May; 36(5):829-36. PMID: 7738660.
      View in: PubMed
    171. Lewis JP, Denardo GL, Denardo SJ. Radioimmunotherapy of lymphoma: a UC Davis experience. Hybridoma. 1995 Apr; 14(2):115-20. PMID: 7590765.
      View in: PubMed
    172. De Nardo GL, Kroger LA, Mirick GR, Lamborn KR, De Nardo SJ. Analysis of antiglobulin (HAMA) response in a group of patients with B-lymphocytic malignancies treated with 131I-Lym-1. Int J Biol Markers. 1995 Apr-Jun; 10(2):67-74. PMID: 7561241.
      View in: PubMed
    173. Kukis DL, DeNardo GL, DeNardo SJ, Mirick GR, Miers LA, Greiner DP, Meares CF. Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates. Cancer Res. 1995 Feb 15; 55(4):878-84. PMID: 7850803.
      View in: PubMed
    174. Macey DJ, DeNardo SJ, DeNardo GL, DeNardo DA, Shen S. Estimation of radiation absorbed doses to the red marrow in radioimmunotherapy. Clin Nucl Med. 1995 Feb; 20(2):117-25. PMID: 7720301.
      View in: PubMed
    175. Wilder RB, Denardo GL, Denardo SJ. Treatment of cancer with intratumoral infusion of radioisotopes. Int J Radiat Oncol Biol Phys. 1994 Oct 15; 30(3):737-9; discussion 745-6. PMID: 7928510.
      View in: PubMed
    176. Shen S, DeNardo GL, DeNardo SJ. Quantitative bremsstrahlung imaging of yttrium-90 using a Wiener filter. Med Phys. 1994 Sep; 21(9):1409-17. PMID: 7838052.
      View in: PubMed
    177. Shen S, DeNardo GL, Yuan A, DeNardo DA, DeNardo SJ. Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung. J Nucl Med. 1994 Aug; 35(8):1381-9. PMID: 8046498.
      View in: PubMed
    178. DeNardo GL, Lewis JP, DeNardo SJ, O'Grady LF. Effect of Lym-1 radioimmunoconjugate on refractory chronic lymphocytic leukemia. Cancer. 1994 Mar 01; 73(5):1425-32. PMID: 8111709.
      View in: PubMed
    179. Kukis DL, Diril H, Greiner DP, DeNardo SJ, DeNardo GL, Salako QA, Meares CF. A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates. Cancer. 1994 Feb 01; 73(3 Suppl):779-86. PMID: 8306260.
      View in: PubMed
    180. DeNardo GL, Kroger LA, DeNardo SJ, Miers LA, Salako Q, Kukis DL, Fand I, Shen S, Renn O, Meares CF. Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3). Cancer. 1994 Feb 01; 73(3 Suppl):1012-22. PMID: 8306243.
      View in: PubMed
    181. DeNardo GL, DeNardo SJ, Macey DJ, Shen S, Kroger LA. Overview of radiation myelotoxicity secondary to radioimmunotherapy using 131I-Lym-1 as a model. Cancer. 1994 Feb 01; 73(3 Suppl):1038-48. PMID: 8306246.
      View in: PubMed
    182. DeNardo SJ, Mirick GR, Kroger LA, O'Grady LF, Erickson KL, Yuan A, Lamborn KR, Hellstrom I, Hellstrom KE, DeNardo GL. The biologic window for chimeric L6 radioimmunotherapy. Cancer. 1994 Feb 01; 73(3 Suppl):1023-32. PMID: 8306244.
      View in: PubMed
    183. DeNardo GL, Lamborn KR, DeNardo SJ, Kroger LA. Use of response surface statistical designs to detect effects of biologic response modifiers such as IL-2. Biotechnol Ther. 1994; 5(1-2):15-26. PMID: 7703830.
      View in: PubMed
    184. DeNardo SJ, O'Grady LF, Richman CM, DeNardo GL. Overview of radioimmunotherapy in advanced breast cancer using I-131 chimeric L6. Adv Exp Med Biol. 1994; 353:203-11. PMID: 7527179.
      View in: PubMed
    185. Shi XB, Gumerlock PH, Wellman AA, Meares CF, DeNardo GL, Meyers FJ, DeNardo SJ. Rapid PCR construction of a gene containing Lym-1 antibody variable regions. PCR Methods Appl. 1993 Aug; 3(1):46-53. PMID: 8220184.
      View in: PubMed
    186. Kramer EL, DeNardo SJ, Liebes L, Kroger LA, Noz ME, Mizrachi H, Salako QA, Furmanski P, Glenn SD, DeNardo GL. Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I study. J Nucl Med. 1993 Jul; 34(7):1067-74. PMID: 8315480.
      View in: PubMed
    187. DeNardo GL, Mahe MA, DeNardo SJ, Macey DJ, Mirick GR, Erwin WD, Groch MW. Body and blood clearance and marrow radiation dose of 131I-Lym-1 in patients with B-cell malignancies. Nucl Med Commun. 1993 Jul; 14(7):587-95. PMID: 8355919.
      View in: PubMed
    188. DeNardo GL, Maddock SW, Sgouros G, Scheibe PO, DeNardo SJ. Immunoadsorption: an enhancement strategy for radioimmunotherapy. J Nucl Med. 1993 Jun; 34(6):1020-7. PMID: 8509840.
      View in: PubMed
    189. Quattrocchi KB, Miller CH, Wagner FC, DeNardo SJ, DeNardo GL, Ovodov K, Frank EH. Cell-mediated immunity in severely head-injured patients: the role of suppressor lymphocytes and serum factors. J Neurosurg. 1992 Nov; 77(5):694-9. PMID: 1403109.
      View in: PubMed
    190. DeNardo SJ, DeNardo GL, Richman CM. Enhancement of clinical radioimmunotherapy for cancer and the role of cytokines. J Natl Cancer Inst. 1992 Mar 18; 84(6):374-5. PMID: 1538409.
      View in: PubMed
    191. DeNardo SJ, Warhoe KA, O'Grady LF, Hellstrom I, Hellstrom KE, Mills SL, Macey DJ, Goodnight JE, DeNardo GL. Radioimmunotherapy for breast cancer: treatment of a patient with I-131 L6 chimeric monoclonal antibody. Int J Biol Markers. 1991 Oct-Dec; 6(4):221-30. PMID: 1665501.
      View in: PubMed
    192. DeNardo G, DeNardo S, Kukis D, Diril H, Suey C, Meares C. Strategies for enhancement of radioimmunotherapy. Int J Rad Appl Instrum B. 1991; 18(6):633-40. PMID: 1743986.
      View in: PubMed
    193. DeNardo SJ, O'Grady LF, Macey DJ, Kroger LA, DeNardo GL, Lamborn KR, Levy NB, Mills SL, Hellstrom I, Hellstrom KE. Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategy. Int J Rad Appl Instrum B. 1991; 18(6):621-31. PMID: 1743985.
      View in: PubMed
    194. DeNardo GL, DeNardo SJ. Quo vadis radioimmune imaging? J Nucl Med. 1990 Aug; 31(8):1439-42. PMID: 2384818.
      View in: PubMed
    195. Deshpande SV, DeNardo SJ, Kukis DL, Moi MK, McCall MJ, DeNardo GL, Meares CF. Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent. J Nucl Med. 1990 Apr; 31(4):473-9. PMID: 2324823.
      View in: PubMed
    196. Deshpande SV, Subramanian R, McCall MJ, DeNardo SJ, DeNardo GL, Meares CF. Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo. J Nucl Med. 1990 Feb; 31(2):218-24. PMID: 2107283.
      View in: PubMed
    197. DeNardo GL, DeNardo SJ, O'Grady LF, Levy NB, Adams GP, Mills SL. Fractionated radioimmunotherapy of B-cell malignancies with 131I-Lym-1. Cancer Res. 1990 Feb 01; 50(3 Suppl):1014s-1016s. PMID: 2297713.
      View in: PubMed
    198. DeNardo GL, DeNardo SJ, O'Grady LF, Mills SL, Lewis JP, Macey DJ. Radiation treatment of B cell malignancies with immunoconjugate. Front Radiat Ther Oncol. 1990; 24:194-201; discussion 202-3. PMID: 2341050.
      View in: PubMed
    199. DeNardo SJ, Deshpande SV, Moi MK, Adamas GP, McCall MK, DeNardo GL, Meares CF. Today and tomorrow: radiochemistry for radioimmunotherapy of breast cancer. Front Radiat Ther Oncol. 1990; 24:142-50; discussion 161-5. PMID: 2341049.
      View in: PubMed
    200. Macey DJ, DeNardo GL, DeNardo SJ. A treatment planning program for radioimmunotherapy. Front Radiat Ther Oncol. 1990; 24:123-31; discussion 161-5. PMID: 2341047.
      View in: PubMed
    201. Koblik PD, De Nardo GL, Berger HJ. Current status of immunoscintigraphy in the detection of thrombosis and thromboembolism. Semin Nucl Med. 1989 Jul; 19(3):221-37. PMID: 2669130.
      View in: PubMed
    202. Adams GP, DeNardo SJ, Deshpande SV, DeNardo GL, Meares CF, McCall MJ, Epstein AL. Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice. Cancer Res. 1989 Apr 01; 49(7):1707-11. PMID: 2493983.
      View in: PubMed
    203. DeNardo SJ, DeNardo GL, Peng JS. Pharmaceutical quality control of radiolabeled monoclonal antibodies and their fragments. Am J Physiol Imaging. 1989; 4(1):39-44. PMID: 2647112.
      View in: PubMed
    204. DeNardo GL, Macey DJ, DeNardo SJ, Zhang CG, Custer TR. Quantitative SPECT of uptake of monoclonal antibodies. Semin Nucl Med. 1989 Jan; 19(1):22-32. PMID: 2652304.
      View in: PubMed
    205. Deshpande SV, Denardo SJ, Meares CF, McCall MJ, Adams GP, Denardo GL. Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver. Int J Rad Appl Instrum B. 1989; 16(6):587-97. PMID: 2606714.
      View in: PubMed
    206. Griffith MH, Yorke ED, Wessels BW, DeNardo GL, Neacy WP. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy. J Nucl Med. 1988 Nov; 29(11):1795-809. PMID: 3263479.
      View in: PubMed
    207. Ryan KP, Dillman RO, DeNardo SJ, DeNardo GL, Beauregard J, Hagan PL, Amox DG, Clutter ML, Burnett KG, Rulot CM. Breast cancer imaging with In-111 human IgM monoclonal antibodies: preliminary studies. Radiology. 1988 Apr; 167(1):71-5. PMID: 3347750.
      View in: PubMed
    208. Deshpande SV, DeNardo SJ, Meares CF, McCall MJ, Adams GP, Moi MK, DeNardo GL. Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice. J Nucl Med. 1988 Feb; 29(2):217-25. PMID: 3258025.
      View in: PubMed
    209. Macey DJ, DeNardo GL, DeNardo SJ. Comparison of three boundary detection methods for SPECT using Compton scattered photons. J Nucl Med. 1988 Feb; 29(2):203-7. PMID: 3258024.
      View in: PubMed
    210. Macey DJ, Denardo SJ, Denardo GL, Goodnight JK, Unger MW. Uptake of indium-111-labeled monoclonal antibody ZME-018 as a function of tumor size in a patient with melanoma. Am J Physiol Imaging. 1988; 3(1):1-6. PMID: 3390350.
      View in: PubMed
    211. DeNardo SJ, DeNardo GL, O'Grady LF, Hu E, Sytsma VM, Mills SL, Levy NB, Macey DJ, Miller CH, Epstein AL. Treatment of B cell malignancies with 131I Lym-1 monoclonal antibodies. Int J Cancer Suppl. 1988; 3:96-101. PMID: 3209308.
      View in: PubMed
    212. De Nardo GL, De Nardo SJ, Miyao NP, Mills SL, Peng JS, O'Grady LF, Epstein AL, Young WC. Non-dehalogenation mechanisms for excretion of radioiodine after administration of labeled antibodies. Int J Biol Markers. 1988 Jan-Mar; 3(1):1-9. PMID: 3249042.
      View in: PubMed
    213. Raventos A, DeNardo SJ, DeNardo G. Prospects for radiolabeled monoclonal antibodies in metastatic disease. J Thorac Imaging. 1987 Oct; 2(4):44-9. PMID: 3316685.
      View in: PubMed
    214. DeNardo SJ, DeNardo GL, O'Grady LF, Macey DJ, Mills SL, Epstein AL, Peng JS, McGahan JP. Treatment of a patient with B cell lymphoma by I-131 LYM-1 monoclonal antibodies. Int J Biol Markers. 1987 Jan-Apr; 2(1):49-53. PMID: 3501448.
      View in: PubMed
    215. Cole WC, DeNardo SJ, Meares CF, McCall MJ, DeNardo GL, Epstein AL, O'Brien HA, Moi MK. Comparative serum stability of radiochelates for antibody radiopharmaceuticals. J Nucl Med. 1987 Jan; 28(1):83-90. PMID: 3794813.
      View in: PubMed
    216. Macey DJ, DeNardo GL, DeNardo SJ, Hines HH. Comparison of low- and medium-energy collimators for SPECT imaging with iodine-123-labeled antibodies. J Nucl Med. 1986 Sep; 27(9):1467-74. PMID: 3489084.
      View in: PubMed
    217. Koizumi K, DeNardo GL, DeNardo SJ, Hays MT, Hines HH, Scheibe PO, Peng JS, Macey DJ, Tonami N, Hisada K. Multicompartmental analysis of the kinetics of radioiodinated monoclonal antibody in patients with cancer. J Nucl Med. 1986 Aug; 27(8):1243-54. PMID: 3488377.
      View in: PubMed
    218. O'Grady LF, DeNardo G, DeNardo S. Radiolabelled monoclonal antibodies for the detection of cancer. Am J Physiol Imaging. 1986; 1(1):44-53. PMID: 3330440.
      View in: PubMed
    219. Mills SL, Denardo SJ, Denardo GL, Epstein AL, Peng JS, Colcher D. 123I radiolabeling of monoclonal antibodies for in vivo procedures. Hybridoma. 1986; 5(4):265-75. PMID: 3542804.
      View in: PubMed
    220. DeNardo SJ, Peng JS, DeNardo GL, Mills SL, Epstein AL. Immunochemical aspects of monoclonal antibodies important for radiopharmaceutical development. Int J Rad Appl Instrum B. 1986; 13(4):303-10. PMID: 3466890.
      View in: PubMed
    221. Cole WC, DeNardo SJ, Meares CF, McCall MJ, DeNardo GL, Epstein AL, O'Brien HA, Moi MK. Serum stability of 67Cu chelates: comparison with 111In and 57Co. Int J Rad Appl Instrum B. 1986; 13(4):363-8. PMID: 3539884.
      View in: PubMed
    222. DeNardo GL, DeNardo SJ, Carretta RF, Bogren HG, Jansholt AL, Krohn KA, Peek NF. Correlation of bioscintigraphy, contrast venography, and iodine-125 fibrinogen uptake test. Clin Nucl Med. 1985 Dec; 10(12):880-3. PMID: 4075688.
      View in: PubMed
    223. DeNardo SJ, Bogren HG, DeNardo GL. Detection of thrombophlebitis in the lower extremities: a regional comparison of 123I fibrinogen scintigraphy and contrast venography. AJR Am J Roentgenol. 1985 Nov; 145(5):1045-52. PMID: 3876735.
      View in: PubMed
    224. Adams DA, DeNardo GL, DeNardo SJ, Conboy CB, Bradbury EM. 31P surface-coil NMR analysis of metabolic status in KHJJ tumors. Magn Reson Med. 1985 Oct; 2(5):419-27. PMID: 4094556.
      View in: PubMed
    225. Adams DA, DeNardo GL, DeNardo SJ, Matson GB, Epstein AL, Bradbury EM. Radioimmunotherapy of human lymphoma in athymic, nude mice as monitored by 31P nuclear magnetic resonance. Biochem Biophys Res Commun. 1985 Sep 16; 131(2):1020-7. PMID: 3876832.
      View in: PubMed
    226. DeNardo GL, Raventos A, Hines HH, Scheibe PO, Macey DJ, Hays MT, DeNardo SJ. Requirements for a treatment planning system for radioimmunotherapy. Int J Radiat Oncol Biol Phys. 1985 Feb; 11(2):335-48. PMID: 3882643.
      View in: PubMed
    227. Lillington GA, Stevens RP, DeNardo GL. Bronchoscopic location of bronchopleural fistula with xenon-133. J Nucl Med. 1982 Apr; 23(4):322-3. PMID: 7069496.
      View in: PubMed
    228. DeNardo GL, DeNardo SJ. Thrombosis detection: fibrinogen counting and radionuclide venography. Clin Nucl Med. 1981 Oct; 6(10S):P37-45. PMID: 7296993.
      View in: PubMed
    229. Gorin AB, Kohler J, DeNardo G. Noninvasive measurement of pulmonary transvascular protein flux in normal man. J Clin Invest. 1980 Nov; 66(5):869-77. PMID: 7430349.
      View in: PubMed
    230. Glass EC, DeNardo GL, Hines HH. Immediate renal imaging and renography with 99mTc methylene diphosphonate to assess renal blood flow, excretory function, and anatomy. Radiology. 1980 Apr; 135(1):187-90. PMID: 7360959.
      View in: PubMed
    231. Denardo GL, Denardo SJ. Nuclear medicine-epitomes of progress: iodine 125 fibrinogen uptake test. West J Med. 1978 Nov; 129(5):415-6. PMID: 18748320.
      View in: PubMed
    232. Glass EC, DeNardo GL. Abnormal peripheral distribution of Thallium-201 due to arteriosclerosis. AJR Am J Roentgenol. 1978 Oct; 131(4):718-20. PMID: 102170.
      View in: PubMed
    233. Jansholt AL, Krohn KA, Stadalnik RC, Matolo NM, DeNardo GL. Catabolism and protein binding of Tc-99m pyridoxylideneglutamate. J Nucl Med. 1978 Sep; 19(9):1036-44. PMID: 99499.
      View in: PubMed
    234. Salamanca JE, Stadalnik RC, DeNardo GL. Clinical assessment of combined organ imaging in the diagnosis of subphrenic abscesses. Clin Nucl Med. 1978 Mar; 3(3):113-5. PMID: 657664.
      View in: PubMed
    235. Yeh SH, Stadalnik RC, DeNardo GL, Chau WK. Definitive diagnosis of choledochal cyst by 99mTc-pyridoxylideneglutamate sequential scintiphotography. Clin Nucl Med. 1978 Feb; 3(2):49-52. PMID: 657652.
      View in: PubMed
    236. Peek NF, Hegedus F, DeNardo GL, Lagunas-Solar M, Berman DS. Production and characteristics of 81Rb for myocardial studies. Int J Nucl Med Biol. 1978; 5(6):273-8. PMID: 738843.
      View in: PubMed
    237. Stadalnik RC, DeNardo GL. Isotope imaging in the diagnosis of primary and secondary tumors of the liver. Prog Clin Cancer. 1978; 7:165-80. PMID: 212781.
      View in: PubMed
    238. D'Ambrosia RD, Shoji H, Riggins RS, Stadalnik RC, DeNardo GL. Scintigraphy in the diagnosis of osteonecrosis. Clin Orthop Relat Res. 1978 Jan-Feb; (130):139-43. PMID: 639385.
      View in: PubMed
    239. DeNardo GL, Krohn KA, DeNardo SJ. Comparison of oncophilic radiopharmaceuticals, *I-fibrinogen, 67Ga-citrate, 111In-bleomycin, and *I-bleomycin in tumor-bearing mice. Cancer. 1977 Dec; 40(6):2923-9. PMID: 73412.
      View in: PubMed
    240. DeNardo GL, DeNardo SJ, Barnett CA, Newcomer KA, Jansholt AL, Carretta RF, Rose AW. Assessment of conventional criteria for the early diagnosis of thrombophlebitis with the 125I-fibrinogen uptake test. Radiology. 1977 Dec; 125(3):765-8. PMID: 928706.
      View in: PubMed
    241. Berman DS, Amsterdam EA, Hines HH, Denardo GL, Salel AF, Ikeda R, Jansholt AL, Mason DT. Problem of diffuse cardiac uptake of technetium-99m pyrophosphate in the diagnosis of acute myocardial infarction: enhanced scintigraphic accuracy by computerized selective blood pool subtraction. Am J Cardiol. 1977 Nov; 40(5):768-74. PMID: 200134.
      View in: PubMed
    242. Pollak EW, DeNardo S, Pollak M, DeNardo G, Wolfman EF. Detection of anticoagulation therapy failures in patients with venous thrombosis. Am J Surg. 1977 Aug; 134(2):214-6. PMID: 889034.
      View in: PubMed
    243. Krohn KA, DeNardo SJ, Wheeler DW, DeNardo GL. I-fibrinogen as an oncophilic radiodiagnostic agent: distribution kinetics in tumour-bearing mice. Br J Cancer. 1977 Aug; 36(2):227-34. PMID: 911661.
      View in: PubMed
    244. DeNardo SJ, DeNardo GL. Iodine-123-fibrinogen scintigraphy. Semin Nucl Med. 1977 Jul; 7(3):245-51. PMID: 887945.
      View in: PubMed
    245. DeNardo SJ, Hershgold EJ, DeNardo GL, Krohn KA, Godin DR. Radioactive labeling of protein carboxyl groups on factor VIII: use of carbodiimides for nuclear medicine. J Nucl Med. 1977 May; 18(5):472-7. PMID: 859025.
      View in: PubMed
    246. Berman DS, Amsterdam EA, Hines HH, Salel AF, Bailey GJ, DeNardo GL, Mason DT. New approach to interpretation of technetium-99m pyrophosphate scintigraphy in detection of acute myocardial infarction: clinical assessment of diagnostic accuracy. Am J Cardiol. 1977 Mar; 39(3):341-6. PMID: 320857.
      View in: PubMed
    247. Krohn KA, Meyers JM, DeNardo GL, DeNardo SJ. Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice. J Nucl Med. 1977 Mar; 18(3):276-81. PMID: 65460.
      View in: PubMed
    248. Berman DS, Salel AF, Amsterdam EA, DeNardo GL, Mason DT. Evaluation of myocardial uptake of 99mtechnetium pyrophosphate in clinical exercise-induced ventricular ischemia. Chest. 1977 Mar; 71(3):349-53. PMID: 189975.
      View in: PubMed
    249. Krohn KA, Meyers J, DeNardo GL. Comparison of I-bleomycin prepared by two methods stability and pharmacokinetics in tumor-bearing mice. Radiology. 1977 Jan; 122(1):179-82. PMID: 63131.
      View in: PubMed
    250. Carretta RF, DeNardo SJ, DeNardo GL, Janshalt AL, Rose AW. Early diagnosis of venous thrombosis using 125I-fibrinogen. J Nucl Med. 1977 Jan; 18(1):5-10. PMID: 830829.
      View in: PubMed
    251. Stadalnik RC, Matolo NM, Jansholt AL, Krohn KA, DeNardo GL, Wolfman EF. Technetium-99m pyridoxylideneglutamate (P.G.) cholescintigraphy. Radiology. 1976 Dec; 121(3 Pt. 1):657-61. PMID: 981662.
      View in: PubMed
    252. Lurie AJ, Salel AF, Berman DS, DeNardo GL, Hurley EJ, Mason DT. Determination of improved myocardial perfusion after aortocoronary bypass surgery by exercise rubidium-81 scintigraphy. Circulation. 1976 Dec; 54(6 Suppl):III20-3. PMID: 1086743.
      View in: PubMed
    253. D'Ambrosia RD, Riggins RS, Stadalnik RC, DeNardo GL. Vascularity of the femoral head. Tc diphosphonate scintigraphy validated with tetracycline labeling. Clin Orthop Relat Res. 1976 Nov-Dec; (121):143-8. PMID: 991494.
      View in: PubMed
    254. Berman DS, Salel AF, DeNardo GL, Bell GB, Scheibe PO, Jackson PE, Mason DT. A new constant infusion radioisotopic technique for the noninvasive determination of cardiac output. Med Instrum. 1976 Jul-Aug; 10(4):195-204. PMID: 785164.
      View in: PubMed
    255. Salel AF, Berman DS, DeNardo GL, Mason DT. Radionuclide assessment of nitroglycerin influence on abnormal left ventricular segmental contraction in patients with coronary heart disease. Circulation. 1976 Jun; 53(6):975-82. PMID: 817850.
      View in: PubMed
    256. Miller RR, Lies JE, Carretta RF, Wampold DB, DeNardo GL, Kraus JF, Amsterdam EA, Mason DT. Prevention of lower extremity venous thrombosis by early mobilization. Confirmation in patients with acute myocardial infarction by 125I-fibrinogen uptake and venography. Ann Intern Med. 1976 Jun; 84(6):700-3. PMID: 937882.
      View in: PubMed
    257. DeNardo SJ, Bell GB, DeNardo GL, Carretta RF, Scheibe PO, Imperato TJ, Jackson PE. Diagnosis of cirrhosis and hepatitis by quantitative hepatic and other reticuloendothelial clearance rates. J Nucl Med. 1976 Jun; 17(6):449-59. PMID: 1262962.
      View in: PubMed
    258. Berman DS, Salel AF, DeNardo GL, Bogren HG, Mason DT. Clinical assessment of left ventricular regional contraction patterns and ejection fraction by high-resolution gated scintigraphy. J Nucl Med. 1975 Oct; 16(10):865-74. PMID: 809551.
      View in: PubMed
    259. Berman DS, Salel AF, DeNardo GL, Mason DT. Noninvasive detection of regional myocardial ischemia using rubidium-81 and the scintillation camera: comparison with stress electrocardiography in patients with arteriographically documented coronary stenosis. Circulation. 1975 Oct; 52(4):619-26. PMID: 1157274.
      View in: PubMed
    260. Denardo GL. Letter: "Polyphosphate bone scans, 32phosphorus, and adenocarcinoma of the thyroid". J Nucl Med. 1975 Oct; 16(10):963-4. PMID: 1177037.
      View in: PubMed
    261. Meyers J, Krohn K, DeNardo G. Preparation and chemical characterization of radioiodinated bleomycin. J Nucl Med. 1975 Sep; 16(9):835-8. PMID: 51079.
      View in: PubMed
    262. Stadalnik RC, DeNardo SJ, DeNardo GL, Raventos A. Critical evaluation of hepatic scintiangiography for neoplastic tumors of the liver. J Nucl Med. 1975 Jul; 16(7):595-601. PMID: 168325.
      View in: PubMed
    263. Bublin AB, Stadalnik RC, DeNardo GL, Vogel JM. Scintigraphic imaging of a blind-ending ureteral duplication. J Nucl Med. 1975 Mar; 16(3):208-9. PMID: 1113169.
      View in: PubMed
    264. Stadalnik RC, Riggins RL, D'Ambrosia R, DeNardo GL. Vascularity of the femoral head: 18fluorine scintigraphy validated with tetracycline labeling. Radiology. 1975 Mar; 114(3):663-6. PMID: 1118569.
      View in: PubMed
    265. Coates G, DeNardo SJ, DeNardo GL, Troy FA. Pharmacokinetics of radioiodinated streptokinase. J Nucl Med. 1975 Feb; 16(2):136-42. PMID: 1110418.
      View in: PubMed
    266. Hines HH, Peek NF, DeNardo GL, Jansholt AL. Production and characteristics of 125Xe: a new noble gas for in vivo studies. J Nucl Med. 1975 Feb; 16(2):143-7. PMID: 1110419.
      View in: PubMed
    267. D'Ambrosia RD, Riggins RS, Stadalnik RC, DeNardo GL. Experience with 99mTc diphosphonate in studying vascularity of the femoral head. Surg Forum. 1975; 26:521-3. PMID: 1216213.
      View in: PubMed
    268. D'Ambrosia RD, Riggins RS, DeNardo SJ, DeNardo GL. Fluoride-18 scintigraphy in avascular necrotic disorders of bone. Clin Orthop Relat Res. 1975; (107):146-55. PMID: 1132172.
      View in: PubMed
    269. DeNardo GL, Stadalnik RC, DeNardo SJ, Raventos A. Hepatic scintiangiographic patterns. Radiology. 1974 Apr; 111(1):135-41. PMID: 4361195.
      View in: PubMed
    270. Riggins RS, DeNardo GL, D'Ambrosia R, Goldman M. Assessment of circulation in the femoral head by 18F scintigraphy. J Nucl Med. 1974 Mar; 15(3):183-6. PMID: 4813225.
      View in: PubMed
    271. Coates G, Stadalnik RC, Palmer JM, DeNardo GL. Hepatic scintiangiography in malignant parasitic tumors. J Nucl Med. 1974 Feb; 15(2):137-9. PMID: 4810586.
      View in: PubMed
    272. Hammel CF, DeNardo SJ, DeNardo GL, Lewis JP. Bone marrow and bone mineral scintigraphic studies in sickle cell disease. Br J Haematol. 1973 Nov; 25(5):593-8. PMID: 4753225.
      View in: PubMed
    273. D'Ambrosia RD, Riggins RS, DeNardo G. 18-F scintigraphy in diagnosis and management of avascular necrosis bone disorders. Surg Forum. 1973; 24:473-4. PMID: 4806068.
      View in: PubMed
    274. Harell GS, DeNardo GL, Archibald RW, Bradley BR, Zboralske FF. Regional distribution of feline esophageal blood flow. Gastroenterology. 1972 Oct; 63(4):627-33. PMID: 4562019.
      View in: PubMed
    275. Fusco MA, Peek NF, Jungerman JA, Zielinski FW, DeNardo SJ, DeNardo GL. Production of carrier-free 123 I using the 127 I(p,5n) 123 Xe reaction. J Nucl Med. 1972 Oct; 13(10):729-32. PMID: 5056687.
      View in: PubMed
    276. Gnekow WC, DeNardo GL, Poole GJ, Kriss JP. Review of a 5-year experience with the radiostrontium bone scintiscan. Calif Med. 1972 Jul; 117(1):1-7. PMID: 5039800.
      View in: PubMed
    277. Silverman S, DeNardo Gl, Glatstein E, Lipton MJ. Evaluation of the liver and spleen in Hodgkin's disease. II. The value of splenic scintigraphy. Am J Med. 1972 Mar; 52(3):362-6. PMID: 5011394.
      View in: PubMed
    278. Lipton MJ, DeNardo GL, Silverman S, Glatstein E. Evaluation of the liver and spleen in Hodgkin's disease. I. The value of hepatic scintigraphy. Am J Med. 1972 Mar; 52(3):356-61. PMID: 5011393.
      View in: PubMed
    279. Kallman RF, DeNardo GL, Stasch MJ. Blood flow in irradiated mouse sarcoma as determined by the clearance of xenon-133. Cancer Res. 1972 Mar; 32(3):483-90. PMID: 5061303.
      View in: PubMed
    280. Fusco MA, Peek NF, Jungermann JA, Zielinski FW, DeNardo SJ, DeNardo GL. Cyclotron production of carrier-free 123 I using the reaction 127 I (p, 5n) 123 Xe. Strahlentherapie Sonderb. 1972; 72:367-75. PMID: 4659353.
      View in: PubMed
    281. Walsh HG, Stasch MJ, DeNardo GL, Crowley LG. Effects of changes of canine portal vein flow on hepatic artery hemodynamics. Surg Forum. 1972; 23(0):354-6. PMID: 4671115.
      View in: PubMed
    282. DeNardo GL, Jacobson SJ, Raventos A. 85 Sr bone scan in neoplastic disease. Semin Nucl Med. 1972 Jan; 2(1):18-30. PMID: 4501055.
      View in: PubMed
    283. Thompson RW, DeNardo GL, Kottra JJ. The diagnostic value of brain scanning in intracranial lymphomas. Radiology. 1972 Jan; 102(1):111-6. PMID: 4550313.
      View in: PubMed
    284. Ray GR, DeNardo GL, King GH. Localization of strontium 85 in soft tissue infected by Aspergillus niger. Radiology. 1971 Oct; 101(1):119-23. PMID: 5111964.
      View in: PubMed
    285. Zboralske FF, Harell GS, DeNardo GL, Bradley B. Distribution of blood flow to the muscle and mucosa of the rat esophagus. Invest Radiol. 1971 Jul-Aug; 6(4):255-9. PMID: 4935917.
      View in: PubMed
    286. Bell RL, DeNardo GL. Enhanced scintigraphic information display using computer-generated ratio techniques. J Nucl Med. 1970 Nov; 11(11):655-9. PMID: 5476926.
      View in: PubMed
    287. Castellino RA, Zatz LM, DeNardo GL. Cerebrospinal-fluid dynamics. N Engl J Med. 1970 Oct 01; 283(14):763. PMID: 5311528.
      View in: PubMed
    288. DeNardo GL. Diagnosis of pulmonary embolism. N Engl J Med. 1970 Aug 27; 283(9):492. PMID: 5434126.
      View in: PubMed
    289. DeNardo GL, Goodwin DA, Ravasini R, Dietrich PA. The ventilatory lung scan in the diagnosis of pulmonary embolism. N Engl J Med. 1970 Jun 11; 282(24):1334-6. PMID: 5444646.
      View in: PubMed
    290. Matin P, Goodwin DA, DeNardo GL. Cerebrospinal fluid scanning and ventricular shunts. Radiology. 1970 Feb; 94(2):435-8. PMID: 5412820.
      View in: PubMed
    291. Duwe SA, DeNardo GL, Helikson MA, Watanabe KS, Crowley LG. Studies of nutrient blood flow of the dog liver as measured by 133xenon. Surg Forum. 1970; 21:376-8. PMID: 4936992.
      View in: PubMed
    292. Thompson RW, DeNardo GL. Therapeutic response of intracranial Hodgkin's disease documented by brain scanning. Cancer. 1969 Nov; 24(5):981-4. PMID: 5353949.
      View in: PubMed
    293. Castellino RA, Zatz LM, DeNardo GL. Radioisotope ventriculography in the Arnold-Chiari malformation. Radiology. 1969 Oct; 93(4):817-21. PMID: 5307295.
      View in: PubMed
    294. Duffy GJ, DeNardo GL, Abington RB. Origin and evolution of radioactive pulmonary emboli in man. Radiology. 1968 Dec; 91(6):1175-80. PMID: 5699619.
      View in: PubMed
    295. Weber WG, DeNardo GL, Bergin JJ. Scintiscanning in malignant lymphomatous involvement of bone. Arch Intern Med. 1968 May; 121(5):433-7. PMID: 4868925.
      View in: PubMed
    296. Hofmann WW, DeNardo GL. Sodium flux in myotonic muscular dystrophy. Am J Physiol. 1968 Feb; 214(2):330-6. PMID: 5635877.
      View in: PubMed
    297. DeNardo GL, Crowley L, Pardoe R, Weintraub R. Animal studies with Se75-selenomethionine. J Nucl Med. 1967 May; 8(5):350. PMID: 6032645.
      View in: PubMed
    298. DeNardo GL, Brody JS, Leach PJ, Bowes DJ, Glazier JB. Comparison of the pulmonary distribution of xenon-133 solution and iodine-131 macroaggregated albumin. J Nucl Med. 1967 May; 8(5):344. PMID: 6032636.
      View in: PubMed
    299. DeNardo GL, Gorton RJ. Dynamic studies with radioisotopes. J Nucl Med. 1967 May; 8(5):373. PMID: 6032680.
      View in: PubMed
    300. DeNardo GL, Horner RW, Leach PJ, Bowes DJ. Radioisotope skeletal survey. JAMA. 1967 Apr 10; 200(2):111-3. PMID: 6071376.
      View in: PubMed
    301. Sutherland JD, DeNardo GL, Brown DW. Lung scans with I-131 labelled macroaggregated human serum albumin (maa). Am J Roentgenol Radium Ther Nucl Med. 1966 Oct; 98(2):416-26. PMID: 5925112.
      View in: PubMed
    302. Glazier JB, DeNardo GL. Pulmonary function studied with the xenon-133 scanning technique. Normal values and a postural study. Am Rev Respir Dis. 1966 Aug; 94(2):188-94. PMID: 5915575.
      View in: PubMed
    303. DeNardo GL. The 85-Sr scintiscan in bone disease. Ann Intern Med. 1966 Jul; 65(1):44-53. PMID: 5936666.
      View in: PubMed
    304. DeNardo GL, Volpe JA. Detection of bone lesions with the strontium-85 scintiscan. J Nucl Med. 1966 Mar; 7(3):219-36. PMID: 5952358.
      View in: PubMed
    305. Williams DW, Denardo GL, Zelenik JS. Thyroid function and enovid. Obstet Gynecol. 1966 Feb; 27(2):232-7. PMID: 4160082.
      View in: PubMed
    306. Mann JG, DeNardo GL. Acute intermittent porphyria associated with hyperthyroidism. J Clin Endocrinol Metab. 1965 Sep; 25(9):1151-5. PMID: 5830941.
      View in: PubMed
    307. VOLPE JA, DENARDO GL. THE PREOPERATIVE DIAGNOSIS OF SPLEEN CYSTS BY SCINTISCANNING. REPORT OF A CASE. Am J Roentgenol Radium Ther Nucl Med. 1965 Aug; 94:839-43. PMID: 14320787.
      View in: PubMed
    308. DENARDO GL, RAY JP. Hereditary spherocytosis and infectious mononucleosis, with acquired hemolytic anemia. Report of a case and review of the literature. Am J Clin Pathol. 1963 Mar; 39:284-8. PMID: 14026948.
      View in: PubMed
    309. DENARDO GL, DANIELL HW, CHILD PL, BUCHANAN DP. Coccidioidomycosis complicating Hodgkin's disease, with a note on furaltadone-induced neuropathy. Arch Intern Med. 1962 Oct; 110:476-80. PMID: 13885380.
      View in: PubMed